Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

STABILITY AND COMPATIBILITY STUDIES
STABILITY AND COMPATIBILITY STUDIES Permanent storage and easy retrieval of Journal articles and formulations.
Only $95 per CD
  • Print Journal articles in color from the pdf file for your marketing needs.
  • Eliminate long searches through past issues for articles and formulations.

This CD contains the following articles listed by volume, issue and page number:

STABILITIES, COMPATIBILITIES RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Basic Principles of Lyophilization, Part 1 Vol. 19 No. 6 471
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Vol. 19 No. 6 521
Novel Approaches to Topical Psoriasis Therapy Vol. 19 No. 5 357
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Vol. 19 No. 5 383
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Vol. 19 No. 5 414
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Vol. 19 No. 5 420
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Vol. 19 No. 5 428
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Vol. 19 No. 5 432
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Vol. 19 No. 4 280
Stability of Prednisone in Oral Mix Suspending Vehicle Vol. 19 No. 4 337
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Vol. 19 No. 4 344
Stability of Metronidazole Suspensions Vol. 19 No. 3 248
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Vol. 19 No. 3 261
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Vol. 19 No. 3 268
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Vol. 19 No. 1 38
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Vol. 19 No. 1 70
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Vol. 19 No. 1 73
Stability of Suspensions: Theoretical and Practical Considerations before Compounding Vol. 19 No. 1 78
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Vol. 18 No. 6 456
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Vol. 18 No. 6 479
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Vol. 18 No. 6 516
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Vol. 18 No. 5 418
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Vol. 18 No. 5 427
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers Vol. 18 No. 5 432
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 345
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 4 348
Investigation of Physical and Chemical Stability of an Ointment with Herbals Vol. 18 No. 3 248
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Vol. 18 No. 3 253
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Vol. 18 No. 3 256
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Vol. 18 No. 2 152
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Vol. 18 No. 2 169
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C Vol. 18 No. 1 78
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Vol. 17 No. 6 508
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes Vol. 17 No. 6 515
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Vol. 17 No. 5 436
Basics of Compounding: Foam Dosage Forms Vol. 17 No. 4 312
Stability of Captopril in SyrSPend SF Vol. 17 No. 4 336
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Vol. 17 No. 4 344
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Vol. 17 No. 4 347
Basics of Compounding: Potency and Stability Testing Vol. 17 No. 3 220
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Vol. 17 No. 3 254
Basics of Compounding: Repackaging, Part 2 Vol. 17 No. 2 136
Stability of Rifampin in SyrSpend SF Vol. 17 No. 2 162
Stability of Minoxidil in Espumil Foam Base Vol. 17 No. 2 165
Beyond-use Date: Establishment and Maintenance Vol. 16 No. 6 471
Stability of Ursodiol in SyrSpend SF Cherry Flavored Vol. 16 No. 6 510
Stability of Propranolol Hydrochloride in SyrSpend SF Vol. 16 No. 6 513
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Vol. 16 No. 6 516
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Vol. 16 No. 5 428
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Vol. 16 No. 4 342
Stability of Gabapentin in SyrSpend SF Vol. 16 No. 4 347
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Vol. 16 No. 3 230
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste Vol. 16 No. 3 258
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Vol. 16 No. 2 164
Stability of Vancomycin in SyrSpend SF Vol. 16 No. 2 167
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method Vol. 16 No. 2 170
Chemical Stability of Pentoxifylline in a Topical Cream Vol. 16 No. 1 80
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Vol. 16 No. 1 82
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Vol. 16 No. 1 62
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 Vol. 15 No. 6 488
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Vol. 15 No. 6 515
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Vol. 15 No. 5 428
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Vol. 15 No. 5 435
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Vol. 15 No. 4 344
Stability of Ertapenem in an Elastomeric Infusion Device Vol. 15 No. 3 252
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Vol. 15 No. 3 255
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Vol. 15 No. 3 259
Drug Compatibility and Stability in Dextrose vs Saline Vol. 15 No. 3 190
Basics of Compounding: Basics of Compounding with Complex Organic Molecules Vol. 15 No. 3 234
Basics of Compounding: Basics of Compounding with Inorganic Salts Vol. 15 No. 2 146
Nifedpine in Compounded Oral and Topical Preparations Vol. 15 No. 2 166
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes Vol. 15 No. 2 170
Maillard Reactions in Pharmaceutical Formulations and Human Health Vol. 15 No. 1 32
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Vol. 15 No. 1 74
Chemical Stability of Brompheniramine Maleate in an Oral Liquid Dosage Form Vol. 15 No. 1 78
Stability of Venlafaxine Immediate-Release Suspensions Vol. 15 No. 1 81
PreScription: Compounding with Manufactured Products Vol. 14 No. 6 448
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Vol. 14 No. 6 522
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study Vol. 14 No. 5 430
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Vol. 14 No. 5 436
Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents Vol. 14 No. 4 284
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Vol. 14 No. 4 342
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Vol. 14 No. 4 346
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Vol. 14 No. 3 232
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration Vol. 14 No. 3 250
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Vol. 14 No. 2 118
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle Vol. 14 No. 1 76
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam Vol. 14 No. 1 78
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Vol. 14 No. 1 82
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding Vol. 13 No. 6 525
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Vol. 13 No. 6 564
Chemical Stability of Scopolamine Hydrobromide Nasal Solution Vol. 13 No. 5 438
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Vol. 13 No. 5 445
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Vol. 13 No. 3 250
Stability of Pergolide Mesylate Oral Liquid at Room Temperature Vol. 13 No. 3 254
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers Vol. 13 No. 2 162
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions Vol. 13 No. 2 166
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Vol. 13 No. 2 170
Identifying the Criteria of a Valid Stability Study Vol. 13 No. 1 32
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Vol. 13 No. 1 78
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Vol. 12 No. 5 456
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Vol. 12 No. 5 460
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Vol. 12 No. 5 463
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Vol. 12 No. 6 524
Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties Vol. 12 No. 6 550
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Vol. 12 No. 6 553
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Vol. 12 No. 6 558
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Vol. 12 No. 4 344
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Vol. 12 No. 4 372
Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Vol. 12 No. 4 368
Chemical Stability of Naltrexone Hydrochloride Injection Vol. 12 No. 3 274
Dilution and Compounding of Ziconotide for Intrathecal Administration Vol. 12 No. 3 200
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Vol. 12 No. 3 276
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Vol. 12 No. 2 130
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Vol. 12 No. 2 156
Chemical Stability of Tramadol Hydrochloride Injection Vol. 12 No. 2 161
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Vol. 12 No. 2 163
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Vol. 12 No. 2 170
Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method Vol. 12 No. 1 50
Room Temperature Stability of Injectable Succinylcholine Dichloride Vol. 12 No. 1 83
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Vol. 11 No. 6 520
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Vol. 11 No. 5 426
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Vol. 11 No. 4 347
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Vol. 11 No. 3 259
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Vol. 11 No. 2 164
Pediatric Oral Formulations: A Continual Challenge Vol. 11 No. 1 17
Sevelamer Suspension in Children with End-Stage Renal Disease Vol. 11 No. 1 20
Chemical Stability of Desonide in Ear Drops Vol. 11 No. 1 79
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Vol. 11 No. 1 82
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Vol. 10 No. 5 396
Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free Vol. 10 No. 4 318
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> Vol. 10 No. 4 309
Stability of Memantine in an Extemporaneously Prepared Oral Liquid Vol. 10 No. 4 316
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Vol. 10 No. 3 230
Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Vol. 10 No. 3 234
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Vol. 10 No. 3 237
Chemical Stability of Diclofenac Sodium Injection Vol. 10 No. 2 154
Extended Stability of Oxytocin in Common Infusion Solutions Vol. 10 No. 2 156
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds Vol. 10 No. 1 74
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Vol. 9 No. 6 482
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Vol. 9 No. 6 484
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Vol. 9 No. 5 396
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Vol. 9 No. 5 399
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Vol. 9 No. 5 402
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Vol. 9 No. 4 320
Stability of Nebulizer Admixtures Vol. 9 No. 4 323
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 235
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 238
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Vol. 9 No. 2 165
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Vol. 9 No. 1 72
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Vol. 9 No. 1 82
Stability of Extemporaneous Oral Ribavirin Liquid Preparation Vol. 8 No. 6 486
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Vol. 8 No. 6 489
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Vol. 8 No. 6 492
Book and Literature Reviews Vol. 8 No. 5 324
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Vol. 8 No. 2 147
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Vol. 7 No. 5 386
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Vol. 7 No. 3 233
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags Vol. 7 No. 2 149
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 2 152
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis Vol. 7 No. 2 155
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 7 No. 1 65
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes Vol. 7 No. 1 68
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes Vol. 6 No. 6 468
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 6 475
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes Vol. 6 No. 6 471
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 5 388
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags Vol. 6 No. 5 391
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 6 No. 5 395
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 4 308
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 4 311
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use Vol. 6 No. 4 316
pH and Osmolarity, A Review of Vol. 6 No. 3 216
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags Vol. 6 No. 3 226
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 3 230
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 6 No. 3 234
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags Vol. 6 No. 2 152
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules Vol. 6 No. 2 155
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 62
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 66
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 70
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 74
Tissue Plasminogen Activator (TPA) 0.5-mg/mL, 1.0-mg/mL, or 2.0-mg/mL for Catheter Occlusion Vol. 5 No. 6 456
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Vol. 5 No. 6 480
Stability of Pentobarbital Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Repackaging in Glass and Polypropylene Syringes Vol. 5 No. 6 482
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 5 No. 5 394
Assessment of the Stability of Teicoplanin in Intravenous Infusions Vol. 5 No. 5 397
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Vol. 5 No. 4 314
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Vol. 5 No. 4 323
Irrigation with Piperacillin for the Treatment of Bladder Infection: A Case Study Vol. 5 No. 3 195
Stability of Piperacillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 3 230
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Vol. 5 No. 3 232
Chemical Stability of Methylprednisolone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 5 No. 2 148
Stability of Cefepime Hydrochloride After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 2 151
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate Vol. 5 No. 2 153
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Vol. 5 No. 1 9
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Vol. 5 No. 1 69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 75
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate Vol. 4 No .6 476
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No .6 480
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes Vol. 4 No .6 482
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 4 No. 5 396
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets Vol. 4 No. 5 398
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Vol. 4 No. 4 296
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Vol. 4 No. 4 298
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs Vol. 4 No. 4 318
Three Drug Stability Lives Vol. 4 No. 3 190
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs Vol. 4 No. 3 225
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation Vol. 4 No. 3 229
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography Vol. 4 No. 3 233
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Vol. 4 No. 2 146
Effect of Some Antioxidants on the Color Change of White Lotion Vol. 4 No. 2 154
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Vol. 4 No. 2 150
Compounding Intrathecal Medications Vol. 4 No. 1 24
Particulates in Parenterals Vol. 4 No. 1 43
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Vol. 4 No. 1 66
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions Vol. 4 No. 1 69
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids Vol. 4 No. 1 72
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure Vol. 3 No. 6 488
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Vol. 3 No. 5 412
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Vol. 3 No. 5 415
Extemporaneous Formulations in Pediatric Patients Vol. 3 No. 4 274
Parenteral Admixture with Y-Site Administration Vol. 3 No. 4 303
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution Vol. 3 No. 4 306
Veterinary Flavor Suggestions Vol. 3 No. 3 186
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Vol. 3 No. 3 235
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Vol. 3 No. 3 241
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography Vol. 3 No. 3 239
Analysis of Extemporaneous Alprostadil Formulations Vol. 3 No. 2 148
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags Vol. 3 No. 2 156
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks Vol. 3 No. 1 56
Stability of Four Commercial Products Delivered by Mail Order Vol. 3 No. 1 59
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Vol. 3 No. 1 64
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Vol. 3 No. 1 67
Chemical Stability of Meperidine Hydrochloride in Polypropylene Syringes Vol. 2 No. 6 463
Stability of Sufentanil in a Syringe Pump Under Simulated Epidural Infusion Vol. 2 No. 6 466
Stability of Albuterol in Continuous Nebulization Vol. 2 No. 5 394
The Stability of Amphotericin B in a Mixture of Fungizone and Optimoist Vol. 2 No. 4 311
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form Vol. 2 No. 4 314
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Vol. 2 No. 4 318
Stability of Lorazepam in 5% Dextrose Injection Vol. 2 No. 4 322
Paclitaxel Compatibility with IV Express Filter Unit Vol. 2 No. 3 243
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL Vol. 2 No. 3 246
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 2 No. 2 168
Stability of Indomethacin in 0.9% Sodium Chloride Injection Vol. 2 No. 2 170
The pH Value of Urea Solutions in Purified Water Vol. 2 No. 1 76
Physical Compatibility and Chemical Stability of Atracurium Besylate and Midazolam Hydrochloride during Intravenous Coinfusion Vol. 2 No. 1 79
Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Vol. 2 No. 1 89
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 1.Statistics for Continuous Data and Stability Studies Vol. 1 No. 6 395
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes Vol. 1 No. 6 433
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 6 435
Short-Term Stability of Atenolol in Oral Liquid Formulations Vol. 1 No. 6 437
Stability of Clonazepam Suspension in HSC Vehicle Vol. 1 No. 6 440
Drug Stability and Compatibility: Special Considerations for Home Health Care Vol. 1 No. 5 301
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids Vol. 1 No. 5 347
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms Vol. 1 No. 5 349
The Stability of Lisinopril as an Extemporaneous Syrup Vol. 1 No. 5 352
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection Vol. 1 No. 5 354
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions Vol. 1 No. 5 356
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection Vol. 1 No. 4 280
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Vol. 1 No. 4 282
Parenteral Admixture Incompatibilities:An Introduction Vol. 1 No. 3 165
Physical Stability of Urea Topical Formulations Vol. 1 No. 3 168
The Formulation Development and Stability of Spironolactone Suspension Vol. 1 No. 3 195
The Formulation Development and Stability of Metronidazole Suspension Vol. 1 No. 3 200
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections Vol. 1 No. 3 206
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 3 208
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Vol. 1 No. 2 118
The Compatibility of Common Respiratory Therapy Drug Combinations Vol. 1 No. 2 121
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Vol. 1 No. 2 123
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture Vol. 1 No. 2 125
Stability of Allopurinol Suspension Compounded from Tablets Vol. 1 No. 2 128
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 2 132
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Vol. 1 No. 1 49